Salim Abdool Karim

Salim Abdool Karim Salim S. Abdool Karim is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Salim Abdool Karim', query time: 0.02s Refine Results
  1. 1
    Navigating Virology’s Frontiers in Africa: Global Virus Network 2024 Durban Meeting

    Navigating Virology’s Frontiers in Africa: Global Virus Network 2024 Durban Meeting by Maggie L. Bartlett, Rubeshan Perumal, Sten H. Vermund, Salim Abdool Karim

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women.

    Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women. by Vineet Joag, Aida Sivro, Nonhlanhla Yende-Zuma, Hajra Imam, Natasha Samsunder, Quarraisha Abdool Karim, Salim Abdool Karim, Lyle McKinnon, Rupert Kaul

    Published 2018-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    High mortality among patients with tuberculosis accessing primary care facilities: secondary analysis from an open-label cluster-randomised trialResearch in context

    High mortality among patients with tuberculosis accessing primary care facilities: secondary analysis from an open-label cluster-randomised trialResearch in context by Kogieleum Naidoo, Nonhlanhla Yende Zuma, Mikaila Moodley, Felix Made, Rubeshan Perumal, Santhanalakshmi Gengiah, Jacqueline Ngozo, Nesri Padayatchi, Andrew Nunn, Salim Abdool Karim

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial

    Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised... by Nigel Garrett, Sharana Mahomed, Edmund Capparelli, Cheryl Baxter, Nonhlanhla Yende Zuma, Tanuja Gengiah, Derseree Archary, Penny Moore, Natasha Samsunder, Dan H Barouch, John Mascola, Julie Ledgerwood, Lynn Morris, Salim Abdool Karim

    Published 2019-07-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody.

    IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody. by Simone I Richardson, Bronwen E Lambson, Andrew R Crowley, Arman Bashirova, Cathrine Scheepers, Nigel Garrett, Salim Abdool Karim, Nonhlanhla N Mkhize, Mary Carrington, Margaret E Ackerman, Penny L Moore, Lynn Morris

    Published 2019-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: